Advanced International Breast Cancer Course (AIBCC)

Breast cancer represents the front runner in cancer research in many aspects. First, this is a common, chronic and lethal disease where medical interventions are successfully inducing a continuous decline in mortality in spite of increasing incidence. Second, biology drives the entire diagnostic-therapeutic work up of these patients. This is why, nowadays, a breast multidisciplinary team should also include pathologists, molecular biologists, oncogeneticists besides the "classic" clinical specialties. Third, many highly effective interventions are available for each step of the diagnostic and therapeutic work-up of these patients. The increased complexity of the disease, the availability of multiple effective choices and the high expectations of our patients are raising the bar of clinical excellence in this field.
With this goal in mind, the Programme of this international Conference includes lectures on molecular characterization, updated treatments of early and advanced disease, management of difficult cases and hereditary syndromes.
Clinical case discussions and debates are planned to allow a continuous and fruitful exchange of experiences and opinions between speakers and participants.
This 12th Breast Cancer Conference includes a highly qualified international faculty, but will maintain its characteristics of a friendly forum where international opinion leaders and attendees will exchange experiences and share the most exiting advances.
In order to reward scientific excellence and to foster international cooperation, the International Scientific Committee of the 12th AIBCC will award the 6th International Prize for Breast Cancer Research to a scientist who has published a breakthrough paper in the previous year.
We welcome medical oncologists, pathologists, breast surgeons, radiation oncologists and basic scientists to listen to breast cancer leaders and to exchange experiences in a friendly atmosphere.

Addressed to

Gynaecologists and obstetrics, medical oncologists, pathologists, radiologists, radiation oncologists, surgeons. Biologists and nurses.

Official Language

The official language of the Meeting is English. No simultaneous translation will be provided.

CME

Based on Italian regulations, Accademia Nazionale di Medicina (provider n. 31) will assign to the activity CME (31-162332): 8 CME points.

The Meeting is addressed to physicians specialized in oncology, radiodiagnostics, radiotherapy, clinical pathology, general surgery, gynaecology and obstetrics, biologists and nurses. It will not be possible to give credits to physicians specialized in different fields.

The credit certification is subject to:

• attendance at the entire Meeting
• the completion of the Meeting evaluation form
• the completion of the final questionnaire (at least 75% of correct answers)

We would like to remind you to participants that only 1/3 of CME credits acquired during the years 2014/2016 can come from a sponsorship.

UNIVERSITY OF PADUA AWARD FOR ADVANCES IN BREAST CANCER 2016

The Scientific Committee will select young researchers (< 40 years from any country) who have published in an international peer-reviewed journal, as the principal author, a manuscript reporting important clinical or biological advances in breast cancer. Prof. Conte and Prof. Hortobagyi will select the final winner which will be invited to present his/her study during the annual Conference.

Download Application Form

CASE HISTORIES

Participants can send one or more case history to the scientific committee. The selected ones will be discussed during one of the three tumor boards (please see the program).
People sending the selected case histories will have to present them and will have free registration, dinners and accommodation as well as a reimbursement of travel expenses (max of travel reimbursement 200,00 € for Italian participants and €300,00 for European participants).
Case histories should be sent within August 25^th.
A confirmation will be sent by email within September 2^nd.
For further details please click here.

FELLOWSHIPS

Some fellowship (for under 40) will be awarded which will include registration and 3 Hotel nights. Those interested should send the registration form together with a short CV and a motivation letter within August 25^th.
The organizing secretariat will confirm the award of the fellowship within September 2^nd and it will proceed with the organization of logistics.

UNDER 35

Free admission is available for 3 people "under 35". Registration forms will be accepted on a first-come, first-served basis until spaces will be full. The Organization Secretariat will confirm the registration by email.

Preliminary Program

Thursday, September 29^th

9.00

Registration

9.45

Introduction to the Course
Pier Franco Conte, Gabriel N. Hortobagyi

SESSION I - LIFE BEFORE AND AFTER BREAST CANCER

Chairmen: Gabriel N. Hortobagyi, Manuel Zorzi

10.00

Diet before and after breast cancer
Livia S.A. Augustin

10.30

Fertility after breast cancer diagnosis
Fedro Peccatori

11.00

Breast cancer and sexuality
Alessandra Graziottin

11.30

Coffee break

SESSION II - BREAST CANCER IN ITALY

Chairmen: Pier Franco Conte, Stefania Gori

12.00

Breast cancer incidence and mortality over time in Italy
Manuel Zorzi

12.30

The Breast Unit: state of art
Claudio Pilerci

12.50

Indices of appropriateness and efficacy: the Periplo Project
Pier Franco Conte

13.10

Lunch

SESSION III - HIGH RISK WOMEN

Chairmen: Alberto Amadori, Sibylle Loibl

14.00

Identification of high risk women: from family history to multigene assays
Ettore Capoluongo

14.30

Risk reduction strategy and management of mutations carriers
Neda Stjepanovic

15.00

Multidisciplinary Tumor Board 1 – Management of high risk women
Chairmen: Gabriel H. Hortobagyi, Luigi Pescarini
Fellows will present case histories, will ask questions to the audience and the participants will vote their preferred choices. A panel of experts including oncogenetists, radiologists, surgeons, oncologists and representatives of advocacy group will comment the votes and express their opinions.
Participants: Maia Dzhugashvili, Julia Lynn Fishwick, Valentina Guarneri, Sibylle Loibl, Stefania Migliuolo, Marco Montagna, Monica Morrow, Philip Poortmans, Corrado Tinterri.

16.30

Coffee break

SESSION IV - SURGERY

Chairmen: Fernando Bozza, Pier Franco Conte

17.00

In situ carcinomas: state of art
Monica Morrow

17.20

Positive sentinel node: when axillary dissection can be spared
Corrado Tinterri

17.40

Lipofilling and breast reconstruction: all good or some risks?
Roberto Gennari

18.00

Discussion

18.30

Adjourn

Friday, September 30^th

SESSION V - BREAST CANCER SUBTYPES: ACTIONABLE PROGNOSTIC AND PREDICTIVE PATHWAYS

Chairmen: Pier Franco Conte, Philip Poortmans

9.00

Triple negative breast cancer
Aleix Prat

9.30

HER2+ breast cancers
Sibylle Loibl

10.00

HR+ breast cancers
Stephen Johnston

10.30

Multiple assays to predict risk of early and late recurrence and benefit of treatment in HR+ disease
Gabriel N. Hortobagyi

10.30

Coffee break

11.30

Multidisciplinary Tumor Board 2 – Biological characterization and adjuvant algorithms
Chairmen: Gabriel N. Hortobagyi, Philip Poortmans
Fellows will present case histories, will ask questions to the audience and the participants will vote their preferred choices. A panel of experts including oncologists, pathologists, radiation oncologists, surgeons and representatives of advocacy group will comment the votes and express their opinions.
Participants: Pier Franco Conte, Julia Lynn Fishwick, Jassem Jassek, Stephen Johnston, Sibylle Loibl, Stefania Migliuolo, Sandra Swain, Enrico Orvieto, Aleix Prat, Corrado Tinterri.

13.00

Lunch

SESSION VI – ADJUVANT TREATMENTS OF EARLY BREAST CANCER

Chairman: Sibylle Loibl, Stephen Johnston

14.00

Triple negative disease
Miguel Martin

14.30

HER2+ disease
Valentina Guarneri

15.00

HR+ disease
Jonas Bergh

15.30

Anti-resorptive agents: role in the adjuvant setting
Robert Coleman

16.00

Radiation therapy: local and systemic efficacy
Philip Poortmans

16.30

Immune checkpoint inhibitors: premises and promises
Peter Schmid

17.00

Q&A

17.15

Adjourn

17.45

Ceremony for the presentation of the University of Padua Award for Advances in Breast Cancer 2016

18.00

Lecture of the Awardee

18.30

Cocktail

20.00

Adjourn

The Ceremony and the cocktail will take place in MUSME (Museo di Storia della Medicina , Via Francesco 94, Padova)

Saturday, October 1^st

9.00

Multidisciplinary Tumor Board 3 – Management of advanced breast cancer
Chairmen: Pier Franco Conte, Stefano Merigliano
Fellows will present case histories, will ask questions to the audience and the participants will vote their preferred choices. A panel of experts including oncologists, pathologists, radiologists, radiation oncologists, surgeons and representatives of advocacy group will comment the votes and express their opinions.
Participants: Camillo Aliberti, Jonas Bergh, Julia Lynn Fishwick, Hesham Ahmed Gaballah Elghazaly, Gabriel N. Hortobagyi, Nadia Harbeck, Miguel Martin, Stefania Migliuolo, Donato Nitti, Enrico Orvieto, Philip Poortmans, Aleix Prat, Pietro Ruggieri, Sandra Swain.

11.00

Coffee break

SESSION VII - NEW DRUGS, NEW HOPES

Chairman: Jonas Bergh

11.30

Targeted agents for HR+ disease
Nadia Harbeck

12.00

New antiHER2 agents
Sandra Swain

12.30

Immune check point inhibitors: what we learnt from other tumors
Michele Maio

12.50

Q&A

13.00

Adjourn and final evaluation questionnaire